Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
Novavax, Inc (NASDAQ: NVAX) closed the day trading at $7.17 down -3.24% from the previous closing price of $7.41. In other words, the price has decreased by -$3.24 from its previous closing price. On the day, 3.98 million shares were traded.
Ratios:
For a better understanding of NVAX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.93 and its Current Ratio is at 0.93.
BofA Securities Upgraded its Underperform to Neutral on May 10, 2024, whereas the target price for the stock was revised from $4 to $12.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 13 ’24 when King Rachel K. sold 4,150 shares for $9.02 per share. The transaction valued at 37,435 led to the insider holds 14,770 shares of the business.
YOUNG JAMES F sold 5,400 shares of NVAX for $43,200 on Dec 31 ’24. The Director now owns 51,760 shares after completing the transaction at $8.00 per share. On Dec 24 ’24, another insider, YOUNG JAMES F, who serves as the Director of the company, sold 4,600 shares for $8.48 each. As a result, the insider received 39,008 and left with 57,160 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.30.
Stock Price History:
Over the past 52 weeks, NVAX has reached a high of $23.86, while it has fallen to a 52-week low of $3.81. The 50-Day Moving Average of the stock is -16.90%, while the 200-Day Moving Average is calculated to be -36.85%.
Shares Statistics:
A total of 160.15M shares are outstanding, with a floating share count of 146.14M. Insiders hold about 8.77% of the company’s shares, while institutions hold 60.07% stake in the company.
